C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 417/14 (2006.01) A61K 31/4439 (2006.01) A61K 31/444 (2006.01) A61K 31/497 (2006.01) A61K 31/501 (2006.01) A61K 31/506 (2006.01) A61K 31/53 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) A61P 9/00 (2006.01) A61P 9/10 (2006.01) A61P 13/12 (2006.01) A61P 25/00 (2006.01) A61P 27/02 (2006.01) A61P 43/00 (2006.01) C07D 401/14 (2006.01) C07D 413/14 (2006.01) C07D 417/12 (2006.01) C07D 471/04 (2006.01) C07D 513/04 (2006.01)
Patent
CA 2515841
The present invention relates to a compound which has a glucokinase-activating effect and is useful as a therapeutic agent for diabetes mellitus, being represented by a formula (I): (see formula I) [wherein X1 represents a nitrogen atom, sulfur atom, oxygen atom or the like; R1 represents a 6- to 10-membered aryl group, 5- to 7-membered heteroaryl group or the like; D represents an oxygen atom or sulfur atom; R2 and R3 are the same or different, each representing a hydrogen atom, lower alkyl group or the like; a formula (II) (see formula II) represents an optionally substituted 5- to 7-membered heteroaryl group or the like; a formula (III) (see formula III) represents a monocyclic or bicyclic heteroaryl group] or a pharmaceutically acceptable salt thereof.
L'invention concerne des composés représentés par la formule générale (I) ou des sels pharmaceutiquement acceptables de ces derniers, qui ont un effet d'activation de glucokinase et sont utiles en tant que remèdes contre le diabète : (I), X1 étant azote, soufre, oxygène ou similaire ; R1 est aryle à 6 à 10 éléments, hétéroaryle à 5 à 7 éléments, ou similaire ; D est oxygène ou soufre ; R2 et R3 sont chacun indépendamment hydrogène, alkyl inférieur, ou similaire ; le noyau A de la formule générale (II) : (II) est hétéroaryle à 5 à 7 éléments facultativement substitué ou similaire ; et le noyau B de la formule générale (III) : (III) est un groupe hétéroaryle monocyclique ou bicyclique.
Bamba Makoto
Eiki Jun-Ichi
Mitsuya Morihiro
Nishimura Teruyuki
Sakai Fumiko
Banyu Pharmaceutical Co. Ltd.
Gowling Lafleur Henderson Llp
Msd K.k.
LandOfFree
Novel 2-pyridine carboxamide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel 2-pyridine carboxamide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel 2-pyridine carboxamide derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1877424